Already a member? Click here to login.
Already a member? Click here to login.
A study released today by the Baker Heart and Diabetes Institute shows that people living with diabetes in remote areas are far less likely to access newer diabetes medicines than those in metropolitan areas.
The study, which tracked 1.2 million Australians living with Type 2 diabetes, also found inequities between Australia’s most and least disadvantaged socioeconomic groups.
Senior author, endocrinologist and Deputy Director at the Baker Institute, Professor Jonathan Shaw said the study did not pinpoint a clear avenue to address this discrepancy.
“But it could be worth exploring the impact of access to educational programs. These are not always as widely available in remote settings. Furthermore, doctors in more remote locations are often juggling a higher patient load.”
The study was led by PhD student Mr Jedidiah Morton, and published in the journal Diabetologia.
A study released today by the Baker Heart and Diabetes Institute shows that people living with diabetes in remote areas are far less likely to access newer diabetes medicines than those in metropolitan areas.
The study, which tracked 1.2 million Australians living with Type 2 diabetes, also found inequities between Australia’s most and least disadvantaged socioeconomic groups.
Senior author, endocrinologist and Deputy Director at the Baker Institute, Professor Jonathan Shaw said the study did not pinpoint a clear avenue to address this discrepancy.
“But it could be worth exploring the impact of access to educational programs. These are not always as widely available in remote settings. Furthermore, doctors in more remote locations are often juggling a higher patient load.”
The study was led by PhD student Mr Jedidiah Morton, and published in the journal Diabetologia.
